(19)
(11) EP 4 178 560 A1

(12)

(43) Date of publication:
17.05.2023 Bulletin 2023/20

(21) Application number: 21838077.2

(22) Date of filing: 08.07.2021
(51) International Patent Classification (IPC): 
A61K 31/165(2006.01)
C07F 9/32(2006.01)
C07C 323/62(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/165; C07D 211/46; C07D 211/48; C07C 323/52; C07C 323/60; C07C 53/18; C07D 205/12; C07D 207/12
(86) International application number:
PCT/US2021/040940
(87) International publication number:
WO 2022/011174 (13.01.2022 Gazette 2022/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.07.2020 US 202063049615 P
11.11.2020 US 202063112444 P

(71) Applicant: Klotho Therapeutics, Inc.
Las Vegas, Nevada 89109 (US)

(72) Inventors:
  • PLANTE, James
    Las Vegas, Nevada 89109 (US)
  • RAMAGE, William
    Del Mar, California 92014 (US)
  • SMITH, Christopher
    San Diego, California 92130 (US)
  • BISHOP, Michael
    San Diego, California 92128 (US)

(74) Representative: Lee, Nicholas John et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) WATER SOLUBLE PRODRUGS OF PTBA FOR USE IN HDAC INHIBITION AND ENHANCING RENAL RECOVERY FOLLOWING ACUTE KIDNEY INJURY